866-997-4948(US-Canada Toll Free)

United States Nonsteroidal Anti-inflammatory Drug Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 102 Pages

Notes:
Sales, means the sales volume of Nonsteroidal Anti-inflammatory Drug
Revenue, means the sales value of Nonsteroidal Anti-inflammatory Drug

This report studies sales (consumption) of Nonsteroidal Anti-inflammatory Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Bayer
Actavis
Teva
Mylan
Pfizer
Novartis
Horizon Pharma
Iroko Pharmaceuticals
Hoechst
Xinhua Pharm

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Nonsteroidal Anti-inflammatory Drug in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Nonsteroidal Anti-inflammatory Drug Market Report 2017
1 Nonsteroidal Anti-inflammatory Drug Overview
1.1 Product Overview and Scope of Nonsteroidal Anti-inflammatory Drug
1.2 Classification of Nonsteroidal Anti-inflammatory Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Nonsteroidal Anti-inflammatory Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Nonsteroidal Anti-inflammatory Drug (2012-2022)
1.4.1 United States Nonsteroidal Anti-inflammatory Drug Sales and Growth Rate (2012-2022)
1.4.2 United States Nonsteroidal Anti-inflammatory Drug Revenue and Growth Rate (2012-2022)

2 United States Nonsteroidal Anti-inflammatory Drug Competition by Manufacturers
2.1 United States Nonsteroidal Anti-inflammatory Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nonsteroidal Anti-inflammatory Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nonsteroidal Anti-inflammatory Drug Average Price by Manufactures (2015 and 2016)
2.4 Nonsteroidal Anti-inflammatory Drug Market Competitive Situation and Trends
2.4.1 Nonsteroidal Anti-inflammatory Drug Market Concentration Rate
2.4.2 Nonsteroidal Anti-inflammatory Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Nonsteroidal Anti-inflammatory Drug Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Nonsteroidal Anti-inflammatory Drug Sales and Market Share by States (2012-2017)
3.2 United States Nonsteroidal Anti-inflammatory Drug Revenue and Market Share by States (2012-2017)
3.3 United States Nonsteroidal Anti-inflammatory Drug Price by States (2012-2017)

4 United States Nonsteroidal Anti-inflammatory Drug Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Nonsteroidal Anti-inflammatory Drug Sales and Market Share by Type (2012-2017)
4.2 United States Nonsteroidal Anti-inflammatory Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Nonsteroidal Anti-inflammatory Drug Price by Type (2012-2017)
4.4 United States Nonsteroidal Anti-inflammatory Drug Sales Growth Rate by Type (2012-2017)

5 United States Nonsteroidal Anti-inflammatory Drug Sales (Volume) by Application (2012-2017)
5.1 United States Nonsteroidal Anti-inflammatory Drug Sales and Market Share by Application (2012-2017)
5.2 United States Nonsteroidal Anti-inflammatory Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Nonsteroidal Anti-inflammatory Drug Manufacturers Profiles/Analysis
6.1 Bayer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bayer Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Actavis
6.2.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Actavis Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva
6.3.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Mylan
6.4.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Mylan Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Horizon Pharma
6.7.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Horizon Pharma Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Iroko Pharmaceuticals
6.8.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Iroko Pharmaceuticals Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Hoechst
6.9.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Hoechst Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Xinhua Pharm
6.10.2 Nonsteroidal Anti-inflammatory Drug Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Xinhua Pharm Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Nonsteroidal Anti-inflammatory Drug Manufacturing Cost Analysis
7.1 Nonsteroidal Anti-inflammatory Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nonsteroidal Anti-inflammatory Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nonsteroidal Anti-inflammatory Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nonsteroidal Anti-inflammatory Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Nonsteroidal Anti-inflammatory Drug Market Forecast (2017-2022)
11.1 United States Nonsteroidal Anti-inflammatory Drug Sales, Revenue Forecast (2017-2022)
11.2 United States Nonsteroidal Anti-inflammatory Drug Sales Forecast by Type (2017-2022)
11.3 United States Nonsteroidal Anti-inflammatory Drug Sales Forecast by Application (2017-2022)
11.4 Nonsteroidal Anti-inflammatory Drug Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Nonsteroidal Anti-inflammatory Drug
Table Classification of Nonsteroidal Anti-inflammatory Drug
Figure United States Sales Market Share of Nonsteroidal Anti-inflammatory Drug by Type in 2015
Table Application of Nonsteroidal Anti-inflammatory Drug
Figure United States Sales Market Share of Nonsteroidal Anti-inflammatory Drug by Application in 2015
Figure United States Nonsteroidal Anti-inflammatory Drug Sales and Growth Rate (2012-2022)
Figure United States Nonsteroidal Anti-inflammatory Drug Revenue and Growth Rate (2012-2022)
Table United States Nonsteroidal Anti-inflammatory Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Nonsteroidal Anti-inflammatory Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonsteroidal Anti-inflammatory Drug Sales Share by Manufacturers
Figure 2016 Nonsteroidal Anti-inflammatory Drug Sales Share by Manufacturers
Table United States Nonsteroidal Anti-inflammatory Drug Revenue by Manufacturers (2015 and 2016)
Table United States Nonsteroidal Anti-inflammatory Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nonsteroidal Anti-inflammatory Drug Revenue Share by Manufacturers
Table 2016 United States Nonsteroidal Anti-inflammatory Drug Revenue Share by Manufacturers
Table United States Market Nonsteroidal Anti-inflammatory Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nonsteroidal Anti-inflammatory Drug Average Price of Key Manufacturers in 2015
Figure Nonsteroidal Anti-inflammatory Drug Market Share of Top 3 Manufacturers
Figure Nonsteroidal Anti-inflammatory Drug Market Share of Top 5 Manufacturers
Table United States Nonsteroidal Anti-inflammatory Drug Sales by States (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Sales Share by States (2012-2017)
Figure United States Nonsteroidal Anti-inflammatory Drug Sales Market Share by States in 2015
Table United States Nonsteroidal Anti-inflammatory Drug Revenue and Market Share by States (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Revenue Share by States (2012-2017)
Figure Revenue Market Share of Nonsteroidal Anti-inflammatory Drug by States (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Price by States (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Sales by Type (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Sales Share by Type (2012-2017)
Figure United States Nonsteroidal Anti-inflammatory Drug Sales Market Share by Type in 2015
Table United States Nonsteroidal Anti-inflammatory Drug Revenue and Market Share by Type (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonsteroidal Anti-inflammatory Drug by Type (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Price by Type (2012-2017)
Figure United States Nonsteroidal Anti-inflammatory Drug Sales Growth Rate by Type (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Sales by Application (2012-2017)
Table United States Nonsteroidal Anti-inflammatory Drug Sales Market Share by Application (2012-2017)
Figure United States Nonsteroidal Anti-inflammatory Drug Sales Market Share by Application in 2015
Table United States Nonsteroidal Anti-inflammatory Drug Sales Growth Rate by Application (2012-2017)
Figure United States Nonsteroidal Anti-inflammatory Drug Sales Growth Rate by Application (2012-2017)
Table Bayer Basic Information List
Table Bayer Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Actavis Basic Information List
Table Actavis Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Actavis Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Teva Basic Information List
Table Teva Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Horizon Pharma Basic Information List
Table Horizon Pharma Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Horizon Pharma Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Iroko Pharmaceuticals Basic Information List
Table Iroko Pharmaceuticals Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Iroko Pharmaceuticals Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Hoechst Basic Information List
Table Hoechst Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hoechst Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Xinhua Pharm Basic Information List
Table Xinhua Pharm Nonsteroidal Anti-inflammatory Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Xinhua Pharm Nonsteroidal Anti-inflammatory Drug Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonsteroidal Anti-inflammatory Drug
Figure Manufacturing Process Analysis of Nonsteroidal Anti-inflammatory Drug
Figure Nonsteroidal Anti-inflammatory Drug Industrial Chain Analysis
Table Raw Materials Sources of Nonsteroidal Anti-inflammatory Drug Major Manufacturers in 2015
Table Major Buyers of Nonsteroidal Anti-inflammatory Drug
Table Distributors/Traders List
Figure United States Nonsteroidal Anti-inflammatory Drug Production and Growth Rate Forecast (2017-2022)
Figure United States Nonsteroidal Anti-inflammatory Drug Revenue and Growth Rate Forecast (2017-2022)
Table United States Nonsteroidal Anti-inflammatory Drug Production Forecast by Type (2017-2022)
Table United States Nonsteroidal Anti-inflammatory Drug Consumption Forecast by Application (2017-2022)
Table United States Nonsteroidal Anti-inflammatory Drug Sales Forecast by States (2017-2022)
Table United States Nonsteroidal Anti-inflammatory Drug Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *